2020
DOI: 10.17294/2330-0698.1744
|View full text |Cite
|
Sign up to set email alerts
|

Characterizing Recurrence Following Hybrid Ablation in Patients With Persistent Atrial Fibrillation

Abstract: Journal of Patient-Centered Research and Reviews (JPCRR) is an open access, peer-reviewed medical journal focused on disseminating scholarly works devoted to improving patient-centered care practices, health outcomes, and the patient experience. Purpose It is widely accepted that atrial fibrillation (AF) accounts for half of arrhythmia recurrences following endocardial catheter ablation of AF. An epicardial-endocardial approach (hybrid) has emerged as an alternative to endocardial ablation alone for the treatm… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
14
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(14 citation statements)
references
References 34 publications
0
14
0
Order By: Relevance
“…27,29,31 A single-center study reported their experience of hybrid convergent procedures using a previous generation unipolar RF device and found no statistical differences in recurrence rates of atrial arrhythmias or AF in patients who did and did not have prior ablation. 36 There were significantly higher incidences of need for intraprocedural PVI and intraprocedural direct current cardioversion in patients who did not have prior ablation than those who had prior ablation. Further evaluation in multicenter settings could shed more insight into expected procedural and follow-up outcomes based on previous ablation history.…”
Section: Other Ablation Studies In Advanced Afmentioning
confidence: 85%
See 1 more Smart Citation
“…27,29,31 A single-center study reported their experience of hybrid convergent procedures using a previous generation unipolar RF device and found no statistical differences in recurrence rates of atrial arrhythmias or AF in patients who did and did not have prior ablation. 36 There were significantly higher incidences of need for intraprocedural PVI and intraprocedural direct current cardioversion in patients who did not have prior ablation than those who had prior ablation. Further evaluation in multicenter settings could shed more insight into expected procedural and follow-up outcomes based on previous ablation history.…”
Section: Other Ablation Studies In Advanced Afmentioning
confidence: 85%
“…Cryoballoon for PVI has been adopted and while it was not permitted in CONVERGE, some investigators have reported on its use in the hybrid convergent procedures. 28,35,36 Several questions also remain regarding the relative effectiveness of the hybrid convergent procedure in subpopulations of patients with advanced AF, such as in those patients with prior ablations compared with those undergoing the procedure de novo.…”
Section: Other Ablation Studies In Advanced Afmentioning
confidence: 99%
“…Of patients with recurrence of arrhythmia, 53% were in atrial flutter and 47% were in AF. Half of ablations for atrial flutter following the hybrid procedure ablated the mitral isthmus [36].…”
Section: The Hybrid Approachmentioning
confidence: 99%
“…A recent single-centre study compared the recurrence of atrial arrhythmias and AF between patients who had a history of prior ablation before hybrid ablation and those who received de novo hybrid ablation and found no significant differences in these outcomes. 72 However, patients who had a history of prior catheter ablation less frequently needed endocardial PVI and cardioversion (to restore sinus rhythm) during the hybrid convergent procedure. Larger, multicentre analyses may be warranted.…”
Section: Hybrid Convergent Ablationmentioning
confidence: 99%
“…CONVERGE and other published studies used irrigated RF catheters for endocardial ablation, however, some investigators have incorporated the use of endocardial cryoballoon in hybrid convergent procedures. 65,72 Endocardial cryoballoon was reported to be non-inferior to RF ablation for paroxysmal AF treatment, and the STOP PERSISTENT AF trial demonstrated safety and effectiveness of endocardial cryoballoon for the treatment of early (duration less than 6 months) persistent AF. 73,15 Outcomes of hybrid convergent ablation using endocardial cryoballoon have not been formally compared with endocardial RF ablation and may be relevant for future evaluation.…”
Section: Hybrid Convergent Ablationmentioning
confidence: 99%